The question then becomes wether production of the new DNA medications will be accepted using the synDNA rather than the fermented variety used during testing and acceptance by FDA. There may be all that potential market out there but if not approved or allowed to produce with the new syn CYGX variety there market in that area is shot for CYGX for a while.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.